Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
The Day the HIV Treatment Pendulum Stopped Swinging

Normally at scientific conferences, even when study findings are considered to be major, a single researcher stands at a podium for 10 or 15 minutes, takes the audience on a guided PowerPoint tour of charts and graphs, receives a round of applause, and fields a few questions. Then the session moves on to its next topic. The presentation of the START findings was different.

Published
23 July 2015
From
The Body Pro
START trial provides definitive evidence of the benefits of early HIV treatment

People who start antiretroviral therapy (ART) immediately after HIV diagnosis, while their CD4 cell count is still high, rather than waiting until it falls below 350 cells/mm3

Published
21 July 2015
By
Liz Highleyman
World Health Organization to recommend HIV treatment for all

The World Health Organization will issue new HIV treatment guidelines later this year recommending treatment for all, regardless of CD4 cell count, Dr Meg Doherty of the

Published
20 July 2015
By
Keith Alcorn
People with HIV live almost 20 years longer than in 2001

People living with the HIV virus today can expect to live nearly two decades longer than those who were diagnosed at the start of this century, thanks to cheaper and more readily available antiretroviral drugs, the UN said in a major report on a disease once seen by many as a death sentence to be endured in secrecy. The average HIV-positive person is now expected to live for 55 years – 19 years longer than in 2001, according to the report by the UN’s Programme on HIV and AIDS (UNAids).

Published
14 July 2015
From
The Guardian
NHS England announces annual investment decisions for certain specialised services [including HIV treatment as prevention]

NHS England has today (2 July) set out its planned investment decisions for certain specialised services as part of its annual commissioning round.

Published
03 July 2015
From
NHS England press release
New British guidelines recommend treatment for everyone with HIV

Everyone with HIV who is prepared to take antiretroviral treatment should receive it, regardless of CD4 cell count, new draft British HIV Association (BHIVA) treatment guidelines

Published
24 June 2015
By
Keith Alcorn
START Making Sense

The story of the START trial will continue to be told for a long time to come. For some it will be a tale of rigorous perseverance in the face of strong counter-prevailing headwinds and ultimate arrival at a result that is solid and conclusive. Others will see a single-minded and aggressive defense of a trial by investigators who refused to accept not only the obvious but also the evidence that rendered their design obsolete and even unethical.

Published
19 June 2015
From
North Carolina AIDS Training and Education Center
When to START has never been clearer

Posirtive Lite editor Bob Leahy in conversation with CATIE’s Sean Hosein about START, the important and ground-breaking study that recently provided definitive evidence of the health benefits of starting HIV treatment sooner rather than later.

Published
10 June 2015
From
Positive Lite
Early HIV Treatment Is Essential, But So Is Testing And Linkage To Care

Last week’s announcement of the Strategic Timing of AntiRetroviral Treatment (START) trial results confirms what many experts have long believed — early treatment for HIV reduces illness and death. While START further establishes the vital role of early antiretroviral therapy (ART), many questions remain on how to actually bring the life-saving benefits of treatment to individual patients.

Published
05 June 2015
From
Health Affairs (blog)
New START Data Fill in When to Start ART, Now the Question is How

It's critical to recognize that figuring out when to start is only part of the puzzle. The question of how to start is equally critical and isn’t going to be settled by any randomized trial. The how concerns the environment in which individuals are offered treatment, the services that are part of that offer—peer support, community-based refills, non-biased provider care, among others—and the ways that the decision to start is framed.

Published
29 May 2015
From
AVAC
← First12345...27Next →

Filter by country